Abivax (ABVX) Announces $150M ATM Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
November 19, 2024 4:30 PM ESTAbivax Establishes an At-the-Market (ATM) Program on Nasdaq
PARIS, France, November 19, 2024 10:30PM CET Abivax SA (Euronext Paris: FR0012333284 ABVX / Nasdaq - ABVX) (Abivax or the Company), a clinical-stage biotechnology company focused on developing therapeutics that harness the bodys natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, today announced the implementation of an At-The-Market program (ATM Program) allowing the Company to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in... More
